AARD vs GILD: Which Stock is Better?
Side-by-side comparison of Aardvark Therapeutics Inc and Gilead Sciences Inc in 2026
AARD
Aardvark Therapeutics Inc
$15.52
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | AARD | GILD | Winner |
|---|---|---|---|
| Market Cap | $334.66M | $154.99B | GILD |
| P/E Ratio | N/A | 19.34 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | 0.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.7% | GILD |
Analyze AARD
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AARD or GILD a better investment?
Comparing AARD and GILD: Aardvark Therapeutics Inc has a market cap of $334.66M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AARD and GILD?
AARD (Aardvark Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AARD or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AARD or GILD?
GILD has higher revenue growth at 0.0% vs 0.0% for AARD.
Which company is more profitable: AARD or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to 0.0% for AARD.
Which is the larger company: AARD or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $334.66M for AARD.
Should I buy AARD or GILD in 2026?
Both AARD and GILD have investment merit. AARD trades at $15.52 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AARD and GILD stock?
Key differences: Market Cap ($334.66M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.7%).